John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
MetLife
MET
$60B
| $8.45M | 0.04% |
187,476
-646,913
| -78% | -$29.1M |
|
527
Martin Marietta Materials
MLM
$32.1B
| $8.39M | 0.04% |
+60,046
| New | +$7.71M |
|
528
Agnico Eagle Mines
AEM
$109B
| $8.39M | 0.04% |
301,593
+178,690
| +145% | +$5.5M |
|
|
KND
529
DELISTED
Kindred Healthcare
KND
| $8.35M | 0.04% |
351,110
+260,922
| +289% | +$5.29M |
|
530
Avery Dennison
AVY
$13.9B
| $8.33M | 0.04% |
157,448
-15,874
| -9% | -$840K |
|
531
Automatic Data Processing
ADP
$112B
| $8.29M | 0.04% |
96,829
-126,990
| -57% | -$10.9M |
|
532
Alliant Energy
LNT
$17.6B
| $8.29M | 0.04% |
263,008
+250,266
| +1,964% | +$8.15M |
|
533
Ashland
ASH
$3.33B
| $8.28M | 0.04% |
132,983
+43,619
| +49% | +$2.64M |
|
|
DNY
534
DELISTED
DONNELLEY R R & SONS CO
DNY
| $8.28M | 0.04% |
431,375
+378,750
| +720% | +$7.27M |
|
|
JAH
535
DELISTED
JARDEN CORPORATION
JAH
| $8.25M | 0.04% |
+156,005
| New | +$7.87M |
|
536
Quest Diagnostics
DGX
$27B
| $8.25M | 0.04% |
+107,368
| New | +$7.69M |
|
537
Vince Holding Corp
VNCE
$80.3M
| $8.25M | 0.04% |
44,454
+37,891
| +577% | +$8.48M |
|
|
EQC
538
DELISTED
Equity Commonwealth
EQC
| $8.24M | 0.04% |
310,347
+55,676
| +22% | +$1.46M |
|
|
SGI
539
Somnigroup International
SGI
$13.6B
| $8.2M | 0.04% |
+568,264
| New | +$7.87M |
|
540
Adtran
ADTN
$633M
| $8.19M | 0.04% |
438,617
+414,325
| +1,706% | +$8.81M |
|
|
STMP
541
DELISTED
Stamps.com, Inc.
STMP
| $8.19M | 0.04% |
121,665
-3,862
| -3% | -$206K |
|
542
ICU Medical
ICUI
$4.57B
| $8.12M | 0.04% |
87,146
-35,367
| -29% | -$3.09M |
|
|
COL
543
DELISTED
Rockwell Collins
COL
| $8.07M | 0.04% |
83,587
-521,662
| -86% | -$46.7M |
|
544
Murphy Oil
MUR
$5.36B
| $8.06M | 0.04% |
172,926
-22,331
| -11% | -$1.08M |
|
|
FISV
545
Fiserv Inc
FISV
$28B
| $8.05M | 0.04% |
202,764
-1,010,578
| -83% | -$38.5M |
|
546
Essent Group
ESNT
$6.12B
| $8.02M | 0.04% |
335,207
+124,612
| +59% | +$2.99M |
|
|
TMH
547
DELISTED
Team Health Holdings Inc
TMH
| $8.01M | 0.04% |
+136,854
| New | +$7.76M |
|
548
Assured Guaranty
AGO
$3.27B
| $8M | 0.04% |
303,241
-603,200
| -67% | -$15.6M |
|
|
TIVO
549
DELISTED
TIVO INC
TIVO
| $7.98M | 0.04% |
751,741
+299,670
| +66% | +$3.24M |
|
|
TCF
550
DELISTED
TCF Financial Corporation
TCF
| $7.95M | 0.04% |
505,625
-233,237
| -32% | -$3.59M |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.